Global Rabies Immune Globulin (Equine) Market Growth 2026-2032
The global Rabies Immune Globulin (Equine) market size is predicted to grow from US$ 1293 million in 2025 to US$ 1652 million in 2032; it is expected to grow at a CAGR of 3.6% from 2026 to 2032.
Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.
The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.
LP Information, Inc. (LPI) ' newest research report, the “Rabies Immune Globulin (Equine) Industry Forecast” looks at past sales and reviews total world Rabies Immune Globulin (Equine) sales in 2025, providing a comprehensive analysis by region and market sector of projected Rabies Immune Globulin (Equine) sales for 2026 through 2032. With Rabies Immune Globulin (Equine) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rabies Immune Globulin (Equine) industry.
This Insight Report provides a comprehensive analysis of the global Rabies Immune Globulin (Equine) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rabies Immune Globulin (Equine) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rabies Immune Globulin (Equine) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rabies Immune Globulin (Equine) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rabies Immune Globulin (Equine).
This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Immune Globulin (Equine) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.
The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.
LP Information, Inc. (LPI) ' newest research report, the “Rabies Immune Globulin (Equine) Industry Forecast” looks at past sales and reviews total world Rabies Immune Globulin (Equine) sales in 2025, providing a comprehensive analysis by region and market sector of projected Rabies Immune Globulin (Equine) sales for 2026 through 2032. With Rabies Immune Globulin (Equine) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rabies Immune Globulin (Equine) industry.
This Insight Report provides a comprehensive analysis of the global Rabies Immune Globulin (Equine) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rabies Immune Globulin (Equine) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rabies Immune Globulin (Equine) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rabies Immune Globulin (Equine) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rabies Immune Globulin (Equine).
This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Immune Globulin (Equine) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 1500IU
- 1000IU
- 400IU
- Others
- Clinic
- Hospital
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Grifols
- Serum China
- Premium Serums
- Intas
- Aventis Pasteur India
- Cadila Pharmaceuticals
- Zydus Takeda Healthcare
- Bharat Serums And Vaccines
- GlaxoSmithKline GmbH
- VINS Bioproducts
- CSL Behring
- What is the 10-year outlook for the global Rabies Immune Globulin (Equine) market?
- What factors are driving Rabies Immune Globulin (Equine) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Rabies Immune Globulin (Equine) market opportunities vary by end market size?
- How does Rabies Immune Globulin (Equine) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rabies Immune Globulin (Equine) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Rabies Immune Globulin (Equine) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Rabies Immune Globulin (Equine) by Country/Region, 2021, 2025 & 2032
2.2 Rabies Immune Globulin (Equine) Segment by Type
2.2.1 1500IU
2.2.2 1000IU
2.2.3 400IU
2.2.4 Others
2.2.5 Rabies Immune Globulin (Equine) Sales by Type
2.2.5.1 Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
2.2.5.2 Global Rabies Immune Globulin (Equine) Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Rabies Immune Globulin (Equine) Sale Price by Type (2021-2026)
2.3 Rabies Immune Globulin (Equine) Segment by Application
2.3.1 Clinic
2.3.2 Hospital
2.3.3 Rabies Immune Globulin (Equine) Sales by Application
2.3.3.1 Global Rabies Immune Globulin (Equine) Sale Market Share by Application (2021-2026)
2.3.3.2 Global Rabies Immune Globulin (Equine) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Rabies Immune Globulin (Equine) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Rabies Immune Globulin (Equine) Breakdown Data by Company
3.1.1 Global Rabies Immune Globulin (Equine) Annual Sales by Company (2021-2026)
3.1.2 Global Rabies Immune Globulin (Equine) Sales Market Share by Company (2021-2026)
3.2 Global Rabies Immune Globulin (Equine) Annual Revenue by Company (2021-2026)
3.2.1 Global Rabies Immune Globulin (Equine) Revenue by Company (2021-2026)
3.2.2 Global Rabies Immune Globulin (Equine) Revenue Market Share by Company (2021-2026)
3.3 Global Rabies Immune Globulin (Equine) Sale Price by Company
3.4 Key Manufacturers Rabies Immune Globulin (Equine) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rabies Immune Globulin (Equine) Product Location Distribution
3.4.2 Players Rabies Immune Globulin (Equine) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RABIES IMMUNE GLOBULIN (EQUINE) BY GEOGRAPHIC REGION
4.1 World Historic Rabies Immune Globulin (Equine) Market Size by Geographic Region (2021-2026)
4.1.1 Global Rabies Immune Globulin (Equine) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Rabies Immune Globulin (Equine) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Rabies Immune Globulin (Equine) Market Size by Country/Region (2021-2026)
4.2.1 Global Rabies Immune Globulin (Equine) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Rabies Immune Globulin (Equine) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Rabies Immune Globulin (Equine) Sales Growth
4.4 APAC Rabies Immune Globulin (Equine) Sales Growth
4.5 Europe Rabies Immune Globulin (Equine) Sales Growth
4.6 Middle East & Africa Rabies Immune Globulin (Equine) Sales Growth
5 AMERICAS
5.1 Americas Rabies Immune Globulin (Equine) Sales by Country
5.1.1 Americas Rabies Immune Globulin (Equine) Sales by Country (2021-2026)
5.1.2 Americas Rabies Immune Globulin (Equine) Revenue by Country (2021-2026)
5.2 Americas Rabies Immune Globulin (Equine) Sales by Type (2021-2026)
5.3 Americas Rabies Immune Globulin (Equine) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Immune Globulin (Equine) Sales by Region
6.1.1 APAC Rabies Immune Globulin (Equine) Sales by Region (2021-2026)
6.1.2 APAC Rabies Immune Globulin (Equine) Revenue by Region (2021-2026)
6.2 APAC Rabies Immune Globulin (Equine) Sales by Type (2021-2026)
6.3 APAC Rabies Immune Globulin (Equine) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rabies Immune Globulin (Equine) by Country
7.1.1 Europe Rabies Immune Globulin (Equine) Sales by Country (2021-2026)
7.1.2 Europe Rabies Immune Globulin (Equine) Revenue by Country (2021-2026)
7.2 Europe Rabies Immune Globulin (Equine) Sales by Type (2021-2026)
7.3 Europe Rabies Immune Globulin (Equine) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rabies Immune Globulin (Equine) by Country
8.1.1 Middle East & Africa Rabies Immune Globulin (Equine) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Rabies Immune Globulin (Equine) Revenue by Country (2021-2026)
8.2 Middle East & Africa Rabies Immune Globulin (Equine) Sales by Type (2021-2026)
8.3 Middle East & Africa Rabies Immune Globulin (Equine) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rabies Immune Globulin (Equine)
10.3 Manufacturing Process Analysis of Rabies Immune Globulin (Equine)
10.4 Industry Chain Structure of Rabies Immune Globulin (Equine)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rabies Immune Globulin (Equine) Distributors
11.3 Rabies Immune Globulin (Equine) Customer
12 WORLD FORECAST REVIEW FOR RABIES IMMUNE GLOBULIN (EQUINE) BY GEOGRAPHIC REGION
12.1 Global Rabies Immune Globulin (Equine) Market Size Forecast by Region
12.1.1 Global Rabies Immune Globulin (Equine) Forecast by Region (2027-2032)
12.1.2 Global Rabies Immune Globulin (Equine) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Rabies Immune Globulin (Equine) Forecast by Type (2027-2032)
12.7 Global Rabies Immune Globulin (Equine) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Grifols
13.1.1 Grifols Company Information
13.1.2 Grifols Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.1.3 Grifols Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Grifols Main Business Overview
13.1.5 Grifols Latest Developments
13.2 Serum China
13.2.1 Serum China Company Information
13.2.2 Serum China Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.2.3 Serum China Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Serum China Main Business Overview
13.2.5 Serum China Latest Developments
13.3 Premium Serums
13.3.1 Premium Serums Company Information
13.3.2 Premium Serums Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.3.3 Premium Serums Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Premium Serums Main Business Overview
13.3.5 Premium Serums Latest Developments
13.4 Intas
13.4.1 Intas Company Information
13.4.2 Intas Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.4.3 Intas Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Intas Main Business Overview
13.4.5 Intas Latest Developments
13.5 Aventis Pasteur India
13.5.1 Aventis Pasteur India Company Information
13.5.2 Aventis Pasteur India Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Aventis Pasteur India Main Business Overview
13.5.5 Aventis Pasteur India Latest Developments
13.6 Cadila Pharmaceuticals
13.6.1 Cadila Pharmaceuticals Company Information
13.6.2 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Cadila Pharmaceuticals Main Business Overview
13.6.5 Cadila Pharmaceuticals Latest Developments
13.7 Zydus Takeda Healthcare
13.7.1 Zydus Takeda Healthcare Company Information
13.7.2 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.7.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Zydus Takeda Healthcare Main Business Overview
13.7.5 Zydus Takeda Healthcare Latest Developments
13.8 Bharat Serums And Vaccines
13.8.1 Bharat Serums And Vaccines Company Information
13.8.2 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bharat Serums And Vaccines Main Business Overview
13.8.5 Bharat Serums And Vaccines Latest Developments
13.9 GlaxoSmithKline GmbH
13.9.1 GlaxoSmithKline GmbH Company Information
13.9.2 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 GlaxoSmithKline GmbH Main Business Overview
13.9.5 GlaxoSmithKline GmbH Latest Developments
13.10 VINS Bioproducts
13.10.1 VINS Bioproducts Company Information
13.10.2 VINS Bioproducts Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 VINS Bioproducts Main Business Overview
13.10.5 VINS Bioproducts Latest Developments
13.11 CSL Behring
13.11.1 CSL Behring Company Information
13.11.2 CSL Behring Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.11.3 CSL Behring Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 CSL Behring Main Business Overview
13.11.5 CSL Behring Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rabies Immune Globulin (Equine) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Rabies Immune Globulin (Equine) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Rabies Immune Globulin (Equine) by Country/Region, 2021, 2025 & 2032
2.2 Rabies Immune Globulin (Equine) Segment by Type
2.2.1 1500IU
2.2.2 1000IU
2.2.3 400IU
2.2.4 Others
2.2.5 Rabies Immune Globulin (Equine) Sales by Type
2.2.5.1 Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
2.2.5.2 Global Rabies Immune Globulin (Equine) Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Rabies Immune Globulin (Equine) Sale Price by Type (2021-2026)
2.3 Rabies Immune Globulin (Equine) Segment by Application
2.3.1 Clinic
2.3.2 Hospital
2.3.3 Rabies Immune Globulin (Equine) Sales by Application
2.3.3.1 Global Rabies Immune Globulin (Equine) Sale Market Share by Application (2021-2026)
2.3.3.2 Global Rabies Immune Globulin (Equine) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Rabies Immune Globulin (Equine) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Rabies Immune Globulin (Equine) Breakdown Data by Company
3.1.1 Global Rabies Immune Globulin (Equine) Annual Sales by Company (2021-2026)
3.1.2 Global Rabies Immune Globulin (Equine) Sales Market Share by Company (2021-2026)
3.2 Global Rabies Immune Globulin (Equine) Annual Revenue by Company (2021-2026)
3.2.1 Global Rabies Immune Globulin (Equine) Revenue by Company (2021-2026)
3.2.2 Global Rabies Immune Globulin (Equine) Revenue Market Share by Company (2021-2026)
3.3 Global Rabies Immune Globulin (Equine) Sale Price by Company
3.4 Key Manufacturers Rabies Immune Globulin (Equine) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rabies Immune Globulin (Equine) Product Location Distribution
3.4.2 Players Rabies Immune Globulin (Equine) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RABIES IMMUNE GLOBULIN (EQUINE) BY GEOGRAPHIC REGION
4.1 World Historic Rabies Immune Globulin (Equine) Market Size by Geographic Region (2021-2026)
4.1.1 Global Rabies Immune Globulin (Equine) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Rabies Immune Globulin (Equine) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Rabies Immune Globulin (Equine) Market Size by Country/Region (2021-2026)
4.2.1 Global Rabies Immune Globulin (Equine) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Rabies Immune Globulin (Equine) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Rabies Immune Globulin (Equine) Sales Growth
4.4 APAC Rabies Immune Globulin (Equine) Sales Growth
4.5 Europe Rabies Immune Globulin (Equine) Sales Growth
4.6 Middle East & Africa Rabies Immune Globulin (Equine) Sales Growth
5 AMERICAS
5.1 Americas Rabies Immune Globulin (Equine) Sales by Country
5.1.1 Americas Rabies Immune Globulin (Equine) Sales by Country (2021-2026)
5.1.2 Americas Rabies Immune Globulin (Equine) Revenue by Country (2021-2026)
5.2 Americas Rabies Immune Globulin (Equine) Sales by Type (2021-2026)
5.3 Americas Rabies Immune Globulin (Equine) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Immune Globulin (Equine) Sales by Region
6.1.1 APAC Rabies Immune Globulin (Equine) Sales by Region (2021-2026)
6.1.2 APAC Rabies Immune Globulin (Equine) Revenue by Region (2021-2026)
6.2 APAC Rabies Immune Globulin (Equine) Sales by Type (2021-2026)
6.3 APAC Rabies Immune Globulin (Equine) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rabies Immune Globulin (Equine) by Country
7.1.1 Europe Rabies Immune Globulin (Equine) Sales by Country (2021-2026)
7.1.2 Europe Rabies Immune Globulin (Equine) Revenue by Country (2021-2026)
7.2 Europe Rabies Immune Globulin (Equine) Sales by Type (2021-2026)
7.3 Europe Rabies Immune Globulin (Equine) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rabies Immune Globulin (Equine) by Country
8.1.1 Middle East & Africa Rabies Immune Globulin (Equine) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Rabies Immune Globulin (Equine) Revenue by Country (2021-2026)
8.2 Middle East & Africa Rabies Immune Globulin (Equine) Sales by Type (2021-2026)
8.3 Middle East & Africa Rabies Immune Globulin (Equine) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rabies Immune Globulin (Equine)
10.3 Manufacturing Process Analysis of Rabies Immune Globulin (Equine)
10.4 Industry Chain Structure of Rabies Immune Globulin (Equine)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rabies Immune Globulin (Equine) Distributors
11.3 Rabies Immune Globulin (Equine) Customer
12 WORLD FORECAST REVIEW FOR RABIES IMMUNE GLOBULIN (EQUINE) BY GEOGRAPHIC REGION
12.1 Global Rabies Immune Globulin (Equine) Market Size Forecast by Region
12.1.1 Global Rabies Immune Globulin (Equine) Forecast by Region (2027-2032)
12.1.2 Global Rabies Immune Globulin (Equine) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Rabies Immune Globulin (Equine) Forecast by Type (2027-2032)
12.7 Global Rabies Immune Globulin (Equine) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Grifols
13.1.1 Grifols Company Information
13.1.2 Grifols Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.1.3 Grifols Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Grifols Main Business Overview
13.1.5 Grifols Latest Developments
13.2 Serum China
13.2.1 Serum China Company Information
13.2.2 Serum China Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.2.3 Serum China Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Serum China Main Business Overview
13.2.5 Serum China Latest Developments
13.3 Premium Serums
13.3.1 Premium Serums Company Information
13.3.2 Premium Serums Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.3.3 Premium Serums Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Premium Serums Main Business Overview
13.3.5 Premium Serums Latest Developments
13.4 Intas
13.4.1 Intas Company Information
13.4.2 Intas Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.4.3 Intas Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Intas Main Business Overview
13.4.5 Intas Latest Developments
13.5 Aventis Pasteur India
13.5.1 Aventis Pasteur India Company Information
13.5.2 Aventis Pasteur India Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Aventis Pasteur India Main Business Overview
13.5.5 Aventis Pasteur India Latest Developments
13.6 Cadila Pharmaceuticals
13.6.1 Cadila Pharmaceuticals Company Information
13.6.2 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Cadila Pharmaceuticals Main Business Overview
13.6.5 Cadila Pharmaceuticals Latest Developments
13.7 Zydus Takeda Healthcare
13.7.1 Zydus Takeda Healthcare Company Information
13.7.2 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.7.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Zydus Takeda Healthcare Main Business Overview
13.7.5 Zydus Takeda Healthcare Latest Developments
13.8 Bharat Serums And Vaccines
13.8.1 Bharat Serums And Vaccines Company Information
13.8.2 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bharat Serums And Vaccines Main Business Overview
13.8.5 Bharat Serums And Vaccines Latest Developments
13.9 GlaxoSmithKline GmbH
13.9.1 GlaxoSmithKline GmbH Company Information
13.9.2 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 GlaxoSmithKline GmbH Main Business Overview
13.9.5 GlaxoSmithKline GmbH Latest Developments
13.10 VINS Bioproducts
13.10.1 VINS Bioproducts Company Information
13.10.2 VINS Bioproducts Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 VINS Bioproducts Main Business Overview
13.10.5 VINS Bioproducts Latest Developments
13.11 CSL Behring
13.11.1 CSL Behring Company Information
13.11.2 CSL Behring Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.11.3 CSL Behring Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 CSL Behring Main Business Overview
13.11.5 CSL Behring Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rabies Immune Globulin (Equine) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Rabies Immune Globulin (Equine) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1500IU
Table 4. Major Players of 1000IU
Table 5. Major Players of 400IU
Table 6. Major Players of Others
Table 7. Global Rabies Immune Globulin (Equine) Sales by Type (2021-2026) & (K Units)
Table 8. Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
Table 9. Global Rabies Immune Globulin (Equine) Revenue by Type (2021-2026) & ($ million)
Table 10. Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2021-2026)
Table 11. Global Rabies Immune Globulin (Equine) Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Rabies Immune Globulin (Equine) Sale by Application (2021-2026) & (K Units)
Table 13. Global Rabies Immune Globulin (Equine) Sale Market Share by Application (2021-2026)
Table 14. Global Rabies Immune Globulin (Equine) Revenue by Application (2021-2026) & ($ million)
Table 15. Global Rabies Immune Globulin (Equine) Revenue Market Share by Application (2021-2026)
Table 16. Global Rabies Immune Globulin (Equine) Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Rabies Immune Globulin (Equine) Sales by Company (2021-2026) & (K Units)
Table 18. Global Rabies Immune Globulin (Equine) Sales Market Share by Company (2021-2026)
Table 19. Global Rabies Immune Globulin (Equine) Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Rabies Immune Globulin (Equine) Revenue Market Share by Company (2021-2026)
Table 21. Global Rabies Immune Globulin (Equine) Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Rabies Immune Globulin (Equine) Producing Area Distribution and Sales Area
Table 23. Players Rabies Immune Globulin (Equine) Products Offered
Table 24. Rabies Immune Globulin (Equine) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Rabies Immune Globulin (Equine) Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Rabies Immune Globulin (Equine) Sales Market Share Geographic Region (2021-2026)
Table 29. Global Rabies Immune Globulin (Equine) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Rabies Immune Globulin (Equine) Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Rabies Immune Globulin (Equine) Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Rabies Immune Globulin (Equine) Sales Market Share by Country/Region (2021-2026)
Table 33. Global Rabies Immune Globulin (Equine) Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Rabies Immune Globulin (Equine) Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Rabies Immune Globulin (Equine) Sales by Country (2021-2026) & (K Units)
Table 36. Americas Rabies Immune Globulin (Equine) Sales Market Share by Country (2021-2026)
Table 37. Americas Rabies Immune Globulin (Equine) Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Rabies Immune Globulin (Equine) Sales by Type (2021-2026) & (K Units)
Table 39. Americas Rabies Immune Globulin (Equine) Sales by Application (2021-2026) & (K Units)
Table 40. APAC Rabies Immune Globulin (Equine) Sales by Region (2021-2026) & (K Units)
Table 41. APAC Rabies Immune Globulin (Equine) Sales Market Share by Region (2021-2026)
Table 42. APAC Rabies Immune Globulin (Equine) Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Rabies Immune Globulin (Equine) Sales by Type (2021-2026) & (K Units)
Table 44. APAC Rabies Immune Globulin (Equine) Sales by Application (2021-2026) & (K Units)
Table 45. Europe Rabies Immune Globulin (Equine) Sales by Country (2021-2026) & (K Units)
Table 46. Europe Rabies Immune Globulin (Equine) Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Rabies Immune Globulin (Equine) Sales by Type (2021-2026) & (K Units)
Table 48. Europe Rabies Immune Globulin (Equine) Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Rabies Immune Globulin (Equine) Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Rabies Immune Globulin (Equine) Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Rabies Immune Globulin (Equine) Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Rabies Immune Globulin (Equine) Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Rabies Immune Globulin (Equine)
Table 54. Key Market Challenges & Risks of Rabies Immune Globulin (Equine)
Table 55. Key Industry Trends of Rabies Immune Globulin (Equine)
Table 56. Rabies Immune Globulin (Equine) Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Rabies Immune Globulin (Equine) Distributors List
Table 59. Rabies Immune Globulin (Equine) Customer List
Table 60. Global Rabies Immune Globulin (Equine) Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Rabies Immune Globulin (Equine) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Rabies Immune Globulin (Equine) Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Rabies Immune Globulin (Equine) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Rabies Immune Globulin (Equine) Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Rabies Immune Globulin (Equine) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Rabies Immune Globulin (Equine) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Rabies Immune Globulin (Equine) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Rabies Immune Globulin (Equine) Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Rabies Immune Globulin (Equine) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Rabies Immune Globulin (Equine) Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Rabies Immune Globulin (Equine) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Rabies Immune Globulin (Equine) Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Rabies Immune Globulin (Equine) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Grifols Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 75. Grifols Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 76. Grifols Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Grifols Main Business
Table 78. Grifols Latest Developments
Table 79. Serum China Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 80. Serum China Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 81. Serum China Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Serum China Main Business
Table 83. Serum China Latest Developments
Table 84. Premium Serums Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 85. Premium Serums Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 86. Premium Serums Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Premium Serums Main Business
Table 88. Premium Serums Latest Developments
Table 89. Intas Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 90. Intas Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 91. Intas Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Intas Main Business
Table 93. Intas Latest Developments
Table 94. Aventis Pasteur India Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 95. Aventis Pasteur India Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 96. Aventis Pasteur India Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Aventis Pasteur India Main Business
Table 98. Aventis Pasteur India Latest Developments
Table 99. Cadila Pharmaceuticals Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 100. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 101. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Cadila Pharmaceuticals Main Business
Table 103. Cadila Pharmaceuticals Latest Developments
Table 104. Zydus Takeda Healthcare Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 105. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 106. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Zydus Takeda Healthcare Main Business
Table 108. Zydus Takeda Healthcare Latest Developments
Table 109. Bharat Serums And Vaccines Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 110. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 111. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Bharat Serums And Vaccines Main Business
Table 113. Bharat Serums And Vaccines Latest Developments
Table 114. GlaxoSmithKline GmbH Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 115. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 116. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. GlaxoSmithKline GmbH Main Business
Table 118. GlaxoSmithKline GmbH Latest Developments
Table 119. VINS Bioproducts Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 120. VINS Bioproducts Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 121. VINS Bioproducts Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. VINS Bioproducts Main Business
Table 123. VINS Bioproducts Latest Developments
Table 124. CSL Behring Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 125. CSL Behring Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 126. CSL Behring Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. CSL Behring Main Business
Table 128. CSL Behring Latest Developments
Table 1. Rabies Immune Globulin (Equine) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Rabies Immune Globulin (Equine) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1500IU
Table 4. Major Players of 1000IU
Table 5. Major Players of 400IU
Table 6. Major Players of Others
Table 7. Global Rabies Immune Globulin (Equine) Sales by Type (2021-2026) & (K Units)
Table 8. Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
Table 9. Global Rabies Immune Globulin (Equine) Revenue by Type (2021-2026) & ($ million)
Table 10. Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2021-2026)
Table 11. Global Rabies Immune Globulin (Equine) Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Rabies Immune Globulin (Equine) Sale by Application (2021-2026) & (K Units)
Table 13. Global Rabies Immune Globulin (Equine) Sale Market Share by Application (2021-2026)
Table 14. Global Rabies Immune Globulin (Equine) Revenue by Application (2021-2026) & ($ million)
Table 15. Global Rabies Immune Globulin (Equine) Revenue Market Share by Application (2021-2026)
Table 16. Global Rabies Immune Globulin (Equine) Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Rabies Immune Globulin (Equine) Sales by Company (2021-2026) & (K Units)
Table 18. Global Rabies Immune Globulin (Equine) Sales Market Share by Company (2021-2026)
Table 19. Global Rabies Immune Globulin (Equine) Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Rabies Immune Globulin (Equine) Revenue Market Share by Company (2021-2026)
Table 21. Global Rabies Immune Globulin (Equine) Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Rabies Immune Globulin (Equine) Producing Area Distribution and Sales Area
Table 23. Players Rabies Immune Globulin (Equine) Products Offered
Table 24. Rabies Immune Globulin (Equine) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Rabies Immune Globulin (Equine) Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Rabies Immune Globulin (Equine) Sales Market Share Geographic Region (2021-2026)
Table 29. Global Rabies Immune Globulin (Equine) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Rabies Immune Globulin (Equine) Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Rabies Immune Globulin (Equine) Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Rabies Immune Globulin (Equine) Sales Market Share by Country/Region (2021-2026)
Table 33. Global Rabies Immune Globulin (Equine) Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Rabies Immune Globulin (Equine) Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Rabies Immune Globulin (Equine) Sales by Country (2021-2026) & (K Units)
Table 36. Americas Rabies Immune Globulin (Equine) Sales Market Share by Country (2021-2026)
Table 37. Americas Rabies Immune Globulin (Equine) Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Rabies Immune Globulin (Equine) Sales by Type (2021-2026) & (K Units)
Table 39. Americas Rabies Immune Globulin (Equine) Sales by Application (2021-2026) & (K Units)
Table 40. APAC Rabies Immune Globulin (Equine) Sales by Region (2021-2026) & (K Units)
Table 41. APAC Rabies Immune Globulin (Equine) Sales Market Share by Region (2021-2026)
Table 42. APAC Rabies Immune Globulin (Equine) Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Rabies Immune Globulin (Equine) Sales by Type (2021-2026) & (K Units)
Table 44. APAC Rabies Immune Globulin (Equine) Sales by Application (2021-2026) & (K Units)
Table 45. Europe Rabies Immune Globulin (Equine) Sales by Country (2021-2026) & (K Units)
Table 46. Europe Rabies Immune Globulin (Equine) Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Rabies Immune Globulin (Equine) Sales by Type (2021-2026) & (K Units)
Table 48. Europe Rabies Immune Globulin (Equine) Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Rabies Immune Globulin (Equine) Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Rabies Immune Globulin (Equine) Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Rabies Immune Globulin (Equine) Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Rabies Immune Globulin (Equine) Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Rabies Immune Globulin (Equine)
Table 54. Key Market Challenges & Risks of Rabies Immune Globulin (Equine)
Table 55. Key Industry Trends of Rabies Immune Globulin (Equine)
Table 56. Rabies Immune Globulin (Equine) Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Rabies Immune Globulin (Equine) Distributors List
Table 59. Rabies Immune Globulin (Equine) Customer List
Table 60. Global Rabies Immune Globulin (Equine) Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Rabies Immune Globulin (Equine) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Rabies Immune Globulin (Equine) Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Rabies Immune Globulin (Equine) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Rabies Immune Globulin (Equine) Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Rabies Immune Globulin (Equine) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Rabies Immune Globulin (Equine) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Rabies Immune Globulin (Equine) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Rabies Immune Globulin (Equine) Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Rabies Immune Globulin (Equine) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Rabies Immune Globulin (Equine) Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Rabies Immune Globulin (Equine) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Rabies Immune Globulin (Equine) Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Rabies Immune Globulin (Equine) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Grifols Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 75. Grifols Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 76. Grifols Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Grifols Main Business
Table 78. Grifols Latest Developments
Table 79. Serum China Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 80. Serum China Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 81. Serum China Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Serum China Main Business
Table 83. Serum China Latest Developments
Table 84. Premium Serums Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 85. Premium Serums Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 86. Premium Serums Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Premium Serums Main Business
Table 88. Premium Serums Latest Developments
Table 89. Intas Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 90. Intas Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 91. Intas Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Intas Main Business
Table 93. Intas Latest Developments
Table 94. Aventis Pasteur India Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 95. Aventis Pasteur India Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 96. Aventis Pasteur India Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Aventis Pasteur India Main Business
Table 98. Aventis Pasteur India Latest Developments
Table 99. Cadila Pharmaceuticals Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 100. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 101. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Cadila Pharmaceuticals Main Business
Table 103. Cadila Pharmaceuticals Latest Developments
Table 104. Zydus Takeda Healthcare Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 105. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 106. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Zydus Takeda Healthcare Main Business
Table 108. Zydus Takeda Healthcare Latest Developments
Table 109. Bharat Serums And Vaccines Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 110. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 111. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Bharat Serums And Vaccines Main Business
Table 113. Bharat Serums And Vaccines Latest Developments
Table 114. GlaxoSmithKline GmbH Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 115. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 116. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. GlaxoSmithKline GmbH Main Business
Table 118. GlaxoSmithKline GmbH Latest Developments
Table 119. VINS Bioproducts Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 120. VINS Bioproducts Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 121. VINS Bioproducts Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. VINS Bioproducts Main Business
Table 123. VINS Bioproducts Latest Developments
Table 124. CSL Behring Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 125. CSL Behring Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 126. CSL Behring Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. CSL Behring Main Business
Table 128. CSL Behring Latest Developments
LIST OF FIGURES
Figure 1. Picture of Rabies Immune Globulin (Equine)
Figure 2. Rabies Immune Globulin (Equine) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rabies Immune Globulin (Equine) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Rabies Immune Globulin (Equine) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Rabies Immune Globulin (Equine) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Rabies Immune Globulin (Equine) Sales Market Share by Country/Region (2025)
Figure 10. Rabies Immune Globulin (Equine) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1500IU
Figure 12. Product Picture of 1000IU
Figure 13. Product Picture of 400IU
Figure 14. Product Picture of Others
Figure 15. Global Rabies Immune Globulin (Equine) Sales Market Share by Type in 2026
Figure 16. Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2021-2026)
Figure 17. Rabies Immune Globulin (Equine) Consumed in Clinic
Figure 18. Global Rabies Immune Globulin (Equine) Market: Clinic (2021-2026) & (K Units)
Figure 19. Rabies Immune Globulin (Equine) Consumed in Hospital
Figure 20. Global Rabies Immune Globulin (Equine) Market: Hospital (2021-2026) & (K Units)
Figure 21. Global Rabies Immune Globulin (Equine) Sale Market Share by Application (2025)
Figure 22. Global Rabies Immune Globulin (Equine) Revenue Market Share by Application in 2026
Figure 23. Rabies Immune Globulin (Equine) Sales by Company in 2026 (K Units)
Figure 24. Global Rabies Immune Globulin (Equine) Sales Market Share by Company in 2026
Figure 25. Rabies Immune Globulin (Equine) Revenue by Company in 2026 ($ millions)
Figure 26. Global Rabies Immune Globulin (Equine) Revenue Market Share by Company in 2026
Figure 27. Global Rabies Immune Globulin (Equine) Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Rabies Immune Globulin (Equine) Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Rabies Immune Globulin (Equine) Sales 2021-2026 (K Units)
Figure 30. Americas Rabies Immune Globulin (Equine) Revenue 2021-2026 ($ millions)
Figure 31. APAC Rabies Immune Globulin (Equine) Sales 2021-2026 (K Units)
Figure 32. APAC Rabies Immune Globulin (Equine) Revenue 2021-2026 ($ millions)
Figure 33. Europe Rabies Immune Globulin (Equine) Sales 2021-2026 (K Units)
Figure 34. Europe Rabies Immune Globulin (Equine) Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Rabies Immune Globulin (Equine) Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Rabies Immune Globulin (Equine) Revenue 2021-2026 ($ millions)
Figure 37. Americas Rabies Immune Globulin (Equine) Sales Market Share by Country in 2026
Figure 38. Americas Rabies Immune Globulin (Equine) Revenue Market Share by Country (2021-2026)
Figure 39. Americas Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
Figure 40. Americas Rabies Immune Globulin (Equine) Sales Market Share by Application (2021-2026)
Figure 41. United States Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Rabies Immune Globulin (Equine) Sales Market Share by Region in 2026
Figure 46. APAC Rabies Immune Globulin (Equine) Revenue Market Share by Region (2021-2026)
Figure 47. APAC Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
Figure 48. APAC Rabies Immune Globulin (Equine) Sales Market Share by Application (2021-2026)
Figure 49. China Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 53. India Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Rabies Immune Globulin (Equine) Sales Market Share by Country in 2026
Figure 57. Europe Rabies Immune Globulin (Equine) Revenue Market Share by Country (2021-2026)
Figure 58. Europe Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
Figure 59. Europe Rabies Immune Globulin (Equine) Sales Market Share by Application (2021-2026)
Figure 60. Germany Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 61. France Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Rabies Immune Globulin (Equine) Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Rabies Immune Globulin (Equine) Sales Market Share by Application (2021-2026)
Figure 68. Egypt Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Rabies Immune Globulin (Equine) in 2026
Figure 74. Manufacturing Process Analysis of Rabies Immune Globulin (Equine)
Figure 75. Industry Chain Structure of Rabies Immune Globulin (Equine)
Figure 76. Channels of Distribution
Figure 77. Global Rabies Immune Globulin (Equine) Sales Market Forecast by Region (2027-2032)
Figure 78. Global Rabies Immune Globulin (Equine) Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Rabies Immune Globulin (Equine) Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Rabies Immune Globulin (Equine) Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Rabies Immune Globulin (Equine) Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Rabies Immune Globulin (Equine) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Rabies Immune Globulin (Equine)
Figure 2. Rabies Immune Globulin (Equine) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rabies Immune Globulin (Equine) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Rabies Immune Globulin (Equine) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Rabies Immune Globulin (Equine) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Rabies Immune Globulin (Equine) Sales Market Share by Country/Region (2025)
Figure 10. Rabies Immune Globulin (Equine) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1500IU
Figure 12. Product Picture of 1000IU
Figure 13. Product Picture of 400IU
Figure 14. Product Picture of Others
Figure 15. Global Rabies Immune Globulin (Equine) Sales Market Share by Type in 2026
Figure 16. Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2021-2026)
Figure 17. Rabies Immune Globulin (Equine) Consumed in Clinic
Figure 18. Global Rabies Immune Globulin (Equine) Market: Clinic (2021-2026) & (K Units)
Figure 19. Rabies Immune Globulin (Equine) Consumed in Hospital
Figure 20. Global Rabies Immune Globulin (Equine) Market: Hospital (2021-2026) & (K Units)
Figure 21. Global Rabies Immune Globulin (Equine) Sale Market Share by Application (2025)
Figure 22. Global Rabies Immune Globulin (Equine) Revenue Market Share by Application in 2026
Figure 23. Rabies Immune Globulin (Equine) Sales by Company in 2026 (K Units)
Figure 24. Global Rabies Immune Globulin (Equine) Sales Market Share by Company in 2026
Figure 25. Rabies Immune Globulin (Equine) Revenue by Company in 2026 ($ millions)
Figure 26. Global Rabies Immune Globulin (Equine) Revenue Market Share by Company in 2026
Figure 27. Global Rabies Immune Globulin (Equine) Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Rabies Immune Globulin (Equine) Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Rabies Immune Globulin (Equine) Sales 2021-2026 (K Units)
Figure 30. Americas Rabies Immune Globulin (Equine) Revenue 2021-2026 ($ millions)
Figure 31. APAC Rabies Immune Globulin (Equine) Sales 2021-2026 (K Units)
Figure 32. APAC Rabies Immune Globulin (Equine) Revenue 2021-2026 ($ millions)
Figure 33. Europe Rabies Immune Globulin (Equine) Sales 2021-2026 (K Units)
Figure 34. Europe Rabies Immune Globulin (Equine) Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Rabies Immune Globulin (Equine) Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Rabies Immune Globulin (Equine) Revenue 2021-2026 ($ millions)
Figure 37. Americas Rabies Immune Globulin (Equine) Sales Market Share by Country in 2026
Figure 38. Americas Rabies Immune Globulin (Equine) Revenue Market Share by Country (2021-2026)
Figure 39. Americas Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
Figure 40. Americas Rabies Immune Globulin (Equine) Sales Market Share by Application (2021-2026)
Figure 41. United States Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Rabies Immune Globulin (Equine) Sales Market Share by Region in 2026
Figure 46. APAC Rabies Immune Globulin (Equine) Revenue Market Share by Region (2021-2026)
Figure 47. APAC Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
Figure 48. APAC Rabies Immune Globulin (Equine) Sales Market Share by Application (2021-2026)
Figure 49. China Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 53. India Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Rabies Immune Globulin (Equine) Sales Market Share by Country in 2026
Figure 57. Europe Rabies Immune Globulin (Equine) Revenue Market Share by Country (2021-2026)
Figure 58. Europe Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
Figure 59. Europe Rabies Immune Globulin (Equine) Sales Market Share by Application (2021-2026)
Figure 60. Germany Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 61. France Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Rabies Immune Globulin (Equine) Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Rabies Immune Globulin (Equine) Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Rabies Immune Globulin (Equine) Sales Market Share by Application (2021-2026)
Figure 68. Egypt Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Rabies Immune Globulin (Equine) Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Rabies Immune Globulin (Equine) in 2026
Figure 74. Manufacturing Process Analysis of Rabies Immune Globulin (Equine)
Figure 75. Industry Chain Structure of Rabies Immune Globulin (Equine)
Figure 76. Channels of Distribution
Figure 77. Global Rabies Immune Globulin (Equine) Sales Market Forecast by Region (2027-2032)
Figure 78. Global Rabies Immune Globulin (Equine) Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Rabies Immune Globulin (Equine) Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Rabies Immune Globulin (Equine) Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Rabies Immune Globulin (Equine) Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Rabies Immune Globulin (Equine) Revenue Market Share Forecast by Application (2027-2032)
